The impact of CD14 polymorphisms on the development of soluble CD14 levels during infancy

T. D. LeVan, S. Guerra, W. Klimecki, M. M. Vasquez, I. C. Lohman, F. D. Martinez, M. Halonen, A. L. Wright

Research output: Contribution to journalArticlepeer-review

23 Scopus citations


CD14 is a receptor involved in the recognition of lipopolysaccharide and other bacterial wall components that may be involved in the balance between infectious and allergic disease and the early polarization towards TH1. Our group has shown an association between polymorphisms in the 5′ flanking region of the CD14 gene and plasma soluble CD14 (sCD14) levels at 11 years of age. However, whether this association is present at birth and in infancy remains to be determined. In this study, we measured sCD14 levels in plasma from the umbilical cord (n = 387) and at 3 months (n = 357) and 1 year (n=312) of age in non-selected healthy infants to assess their relationship with CD14 genotypes at -4190, -2838, -1720 and -260 (relative to translation start site). There was no relation of CD14 genotypes with sCD14 at birth. However, there was a significant association between CD14 genotypes and sCD14 as early as 3 months. Longitudinal analysis suggests that CD14 polymorphisms modulate sCD14 levels up to 1 year of age. This association early in life may have an impact on TH1 polarization and subsequent protection against allergic disease.

Original languageEnglish (US)
Pages (from-to)77-80
Number of pages4
JournalGenes and Immunity
Issue number1
StatePublished - Jan 2006


  • Allergy
  • Atopy
  • CD14
  • Infancy
  • Innate immunity
  • Single nucleotide polymorphism

ASJC Scopus subject areas

  • Immunology
  • Genetics
  • Genetics(clinical)


Dive into the research topics of 'The impact of CD14 polymorphisms on the development of soluble CD14 levels during infancy'. Together they form a unique fingerprint.

Cite this